No Shortage of Hepatitis C Treatments

In 2014, the FDA approved Harvoni (ledipasvir and sofosbuvir) as the first fixed-dose combination drug for hepatitis C. Harvoni combines Sovaldi with a new medication called ledipasvir. Harvoni works by interfering with the enzymes the virus needs to multiply. This drug comes in tablet form and is taken once daily.